Back
Eloxx Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
34
ELOX
Eloxx Pharmaceuticals
Last Price:
0.90
Seasonality Move:
-3.25%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.12
Seasonality Move:
1.9%
Sell
34
Eloxx Pharmaceuticals (ELOX)
is a Sell
Is Eloxx Pharmaceuticals a Buy, Sell or Hold?
- The current Eloxx Pharmaceuticals [ELOX] share price is $0.90. The Score for ELOX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ELOX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.12. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ELOX Stock Price Chart
What is Eloxx Pharmaceuticals's stock price today?
-
The Eloxx Pharmaceuticals share price today is $0.90
The current trend is relatively stagnant and ELOX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
ELOX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.05 | Buy |
| Chaikin Money Flow: | 2654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.82 - 0.94) | Buy |
| Bollinger Bands (100): | (0.82 - 1.06) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 66.72 | Buy |
| Chaikin Money Flow: | -109706734 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Buy |
| Bollinger Bands (100): | (0.09 - 0.17) | Sell |
ELOX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.87 | Buy |
| 20-day SMA: | 0.86 | Buy |
| 50-day SMA: | 0.93 | Sell |
| 200-day SMA: | 2.06 | Sell |
| 8-day EMA: | 0.87 | Buy |
| 20-day EMA: | 0.88 | Buy |
| 50-day EMA: | 0.92 | Sell |
| 200-day EMA: | 2.21 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.1 | Buy |
| 20-day SMA: | 0.09 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.28 | Sell |
| 8-day EMA: | 0.1 | Buy |
| 20-day EMA: | 0.09 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.5 | Sell |
Eloxx Pharmaceuticals Earnings Growth & ELOX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.61 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Eloxx Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||